Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Peter J. 1. Wilkinson | SVP Chief Accounting Officer | 2023-11-16 | 1,384 | $210.71 | $291.63kSell |
Kerrii B. Anderson | Director | 2023-08-08 | 5,000 | $211.57 | $1.06MSell |
Peter J. 1. Wilkinson | SVP Chief Accounting Officer | 2023-08-01 | 17 | $213.61 | $3.63kSell |
Der Vaart Sandra D. Van | EVP Chief Legal Officer | 2023-06-29 | 212 | $240.00 | $50.88kSell |
Paul R. Kirchgraber | CEO Covance Drug Development | 2023-05-19 | 4,300 | $216.91 | $932.71kSell |
Paul R. Kirchgraber | CEO Covance Drug Development | 2023-05-19 | 4,300 | $182.51 | $784.79kBuy |
Mark S. Schroeder | EVP Pres Diagnostics COO | 2023-05-18 | 1,500 | $216.77 | $325.16kSell |
Mark S. Schroeder | EVP Pres Diagnostics COO | 2023-05-18 | 1,500 | $130.60 | $195.90kBuy |
Mark S. Schroeder | EVP President-Diagnostics Lab | 2023-03-31 | 3,897 | $225.81 | $879.98kSell |
Adam H. Schechter | President CEO | 2023-03-30 | 18,646 | $224.70 | $4.19MSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Blackrock Inc | 13.99% | 11,875,219 | $2.58B | Institution |
Vanguard Group Inc | 12.01% | 10,192,449 | $2.21B | Institution |
State Street Corp | 4.51% | 3,826,543 | $830.02M | Institution |
Wellington Management Group LLP | 2.93% | 2,487,106 | $539.48M | Institution |
Morgan Stanley | 2.61% | 2,219,291 | $481.39M | Institution |
Lazard Asset Management LLC | 2.61% | 2,212,497 | $479.91M | Institution |
Geode Capital Management LLC | 2.26% | 1,918,727 | $416.19M | Institution |
Bank Of America Corp | 1.76% | 1,492,395 | $323.72M | Institution |
Dimensional Fund Advisors LP | 1.71% | 1,454,978 | $315.60M | Institution |
Jpmorgan Chase Co | 1.69% | 1,435,709 | $311.42M | Institution |